Asthma Pill Works As Well As Common Inhalers, Study Finds
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study.
British researchers found that tablets called leukotriene receptor antagonists (LTRAs) manage asthma equally successfully as steroid inhalers and other "preventer" inhalers when used in addition to steroid inhalers.
LTRAs -- sold under the brand names Singulair (montelukast) and Accolate (zafirlukast) -- have long been on the market as an alternative to the steroid inhalers commonly used by people with asthma to ward off attacks. However, they are less popular than inhalers, researchers said.
Researchers followed 650 patients with chronic asthma for two years, and found that LTRAs could provide an effective alternative for people who have problems using inhalers or are unable to use them because of side effects.
"We hope these findings will increase the options for health care professionals when prescribing for this common but disruptive disease," study researcher David Price, of the University of Aberdeen and the University of East Anglia in England, said in a statement.
Researchers also found that adherence to asthma treatment was improved by as much as 60 percent among patients given the once-a-day LTRA tablets, since they did not have to worry about using appropriate inhaler techniques, Price said.
Asthma is a chronic condition characterized by inflammation of the airways, causing wheezing, coughing, chest tightness and shortness of breath. About 34.1 million Americans have asthma, according to the American Academy of Allergy, Asthma & Immunology.
Get the world’s most fascinating discoveries delivered straight to your inbox.
The study will be published tomorrow (May 5) in the New England Journal of Medicine.
Pass it on: Asthma drugs called leukotriene receptor antagonists work just as well as the more commonly prescribed inhalers.
Follow MyHealthNewsDaily on Twitter @MyHealth_MHND.
This story was provided by MyHealthNewsDaily, a sister site to LiveScience.

